NeuroMod+ research network successfully funded

March 14, 2022

We are happy to report that an application to establish the NeuroMod+ research network was successfully funded by the EPSRC (£1,265,849).

This research network brings together MedTech businesses, including Neurotherapeutics Ltd, with researchers, clinicians, patients, and medical charities to co-create and develop the next-generation of neuromodulation therapeutics. Neurotherapeutics Ltd will be an active collaborator in this network.

Company number: 13198315 

Registered Office:
The Ingenuity Centre
University Of Nottingham Innovation Park
Triumph Road

Tourettes Friendly Organisation

Privacy Notice       Cookies

Neupulse and Neutrack  are registered trade marks of Neurotherapeutics Ltd

Website by Clifton Media

Back to Top